Purchase Order 75N92026P00052
- Not listed
- The National Heart, Lung and Blood Institute awarded a $24,000 purchase order contract to Genomic Testing Cooperative, LCA, a small disadvantaged business located in Lake Forest, California, for hematology panel sequencing and somatic mutation analysis services. The contract, which commenced on December 22, 2025 and extends through December 21, 2026, requires the contractor to conduct next-generation sequencing of bone marrow samples to identify somatic mutations that will provide guidance for...
- The National Heart, Lung and Blood Institute (NHLBI), a component of the National Institutes of Health within the Department of Health and Human Services, awarded a $24,000 firm fixed-price purchase order contract to Genomic Testing Cooperative, LCA for hematology panel sequencing and somatic mutation analysis of bone marrow samples. The contract, awarded on July 14, 2025, with an ultimate completion date of January 14, 2026, supports the Young Lab's biomedical research initiatives by...
- This is a $24,000.00 firm fixed-price purchase order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to Genomic Testing Cooperative, LCA, a self-certified small disadvantaged business located in Lake Forest, California. The contract is for the provision of a hematology panel, including sequencing somatic mutations in bone marrow samples, in order to provide guidance for the treatment and diagnosis of disease. This contract is not associated with a...
- This is a $45,000.00 firm-fixed-price purchase order contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Heart, Lung and Blood Institute (NHLBI) to Genomic Testing Cooperative, LCA, a self-certified small disadvantaged business. The contract is for the provision of a 177-gene Hematology Panel, in support of NHLBI's biomedical research efforts. The contract does not have a set-aside designation. Genomic Testing Cooperative, LCA has held...
- This is a $24,000.00 firm fixed-price purchase order contract awarded by the National Heart, Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Genomic Testing Cooperative, LCA, a self-certified small disadvantaged business located in Lake Forest, California. The contract is for hematology panel services, specifically the sequencing of somatic mutations in bone marrow samples to provide guidance in the treatment and diagnosis of disease. The contract has...
- This is a firm fixed-price purchase order contract awarded by the National Heart, Lung and Blood Institute (NHLBI), a division of the National Institutes of Health (NIH), to Genomic Testing Cooperative, LCA, a self-certified small disadvantaged business. The contract, valued at $19,500.00, requires the contractor to provide hematology panel testing services, specifically sequencing somatic mutations in bone marrow samples, in order to provide guidance for the treatment and diagnosis of...
- This is a $24,000.00 firm fixed-price purchase order contract awarded by the National Heart, Lung and Blood Institute (NHLBI), a division of the National Institutes of Health (NIH), to Genomic Testing Cooperative, LCA, a small disadvantaged business. The contract is for providing a hematology panel to perform sequencing of somatic mutations in bone marrow samples, which will provide guidance in the treatment and diagnosis of disease. The contract has an ultimate completion date of December 30,...
- This is a $85,500.00 firm fixed-price purchase order contract awarded by the National Heart, Lung and Blood Institute (NHLBI), a division of the National Institutes of Health (NIH), to Genomic Testing Cooperative, LCA, a self-certified small disadvantaged business. The contract is for providing next-generation genomic sequence test services to support biomedical research efforts, with a focus on hematology-related research. The contract does not have a set-aside designation and is scheduled...
- The National Heart, Lung and Blood Institute of the National Institutes of Health, within the Department of Health and Human Services, awarded a $90,000 firm fixed price purchase order to Genomic Testing Cooperative LCA Genomic Testing Cooperative Division. The prime contractor will provide detection of somatic gene mutations in patients to the agency over a one year period of performance in Bethesda, Maryland. This contract has a total small business set aside designation. The award supports...
- The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a firm fixed price purchase order to Genomic Testing Cooperative, LCA, a self-certified small disadvantaged business, for $114,000 to provide next generation sequencing on 177 genes. The contract has a completion date of November 1, 2023. Genomic Testing Cooperative is a tumor profiling laboratory that offers DNA and RNA testing for cancer biomarkers and has previously...
The National Heart, Lung and Blood Institute (NHLBI) awarded a $24,000 firm fixed-price purchase order to Genomic Testing Cooperative, LCA, a small disadvantaged business based in Lake Forest, California, on January 20, 2026. The contract, which has no set-aside designation, requires the contractor to perform hematology panel sequencing on bone marrow samples to identify somatic mutations for the NHLBI's Young Lab. The resulting genetic analysis provides critical guidance for disease diagnosis and treatment decisions, leveraging the contractor's specialized 177-gene next-generation sequencing panel designed to detect mutations relevant to blood disorders and hematologic conditions. This award represents a continuation of an established relationship between NHLBI and Genomic Testing Cooperative, which has received multiple contract awards since 2021 totaling over $650,000 for similar genomic testing services. The contractor's specialized capabilities in tumor profiling and cancer biomarker analysis directly support NHLBI's mission to advance understanding of blood, heart, and lung diseases through precision molecular diagnostics. The contract is scheduled for completion by September 1, 2026, and maintains the firm fixed-price structure typical of NHLBI's engagement with this vendor for routine genomic testing services supporting federal biomedical research initiatives.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.0k | 1/21/26 |